Delta Capital Management LLC trimmed its position in shares of UnitedHealth Group Inc (NYSE:UNH) by 27.1% during the 1st quarter, HoldingsChannel reports. The fund owned 18,671 shares of the healthcare conglomerate’s stock after selling 6,955 shares during the period. UnitedHealth Group makes up approximately 3.0% of Delta Capital Management LLC’s investment portfolio, making the stock its 9th biggest position. Delta Capital Management LLC’s holdings in UnitedHealth Group were worth $4,617,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. Crewe Advisors LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $25,000. Pearl River Capital LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at approximately $35,000. Canton Hathaway LLC bought a new position in shares of UnitedHealth Group during the 1st quarter valued at approximately $36,000. OLD Second National Bank of Aurora increased its position in shares of UnitedHealth Group by 70.0% during the 4th quarter. OLD Second National Bank of Aurora now owns 170 shares of the healthcare conglomerate’s stock valued at $42,000 after purchasing an additional 70 shares during the last quarter. Finally, Laurel Wealth Advisors LLC bought a new position in UnitedHealth Group in the 4th quarter valued at $42,000. 86.15% of the stock is currently owned by institutional investors and hedge funds.
Shares of UNH stock opened at $246.50 on Friday. UnitedHealth Group Inc has a twelve month low of $208.07 and a twelve month high of $287.94. The firm has a market capitalization of $236.96 billion, a price-to-earnings ratio of 19.14, a PEG ratio of 1.34 and a beta of 0.74. The company has a debt-to-equity ratio of 0.63, a current ratio of 0.73 and a quick ratio of 0.73.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $3.73 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.60 by $0.13. UnitedHealth Group had a return on equity of 25.07% and a net margin of 5.45%. The business had revenue of $60.30 billion during the quarter, compared to analysts’ expectations of $59.72 billion. During the same period in the prior year, the business earned $3.04 EPS. The business’s revenue for the quarter was up 9.2% compared to the same quarter last year. As a group, equities analysts forecast that UnitedHealth Group Inc will post 14.71 EPS for the current year.
UNH has been the topic of several research analyst reports. Credit Suisse Group reaffirmed a “buy” rating and issued a $310.00 price objective on shares of UnitedHealth Group in a research report on Friday, February 8th. Zacks Investment Research downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, March 19th. Raymond James cut their price objective on UnitedHealth Group from $310.00 to $265.00 and set a “strong-buy” rating on the stock in a research report on Wednesday, April 17th. Morgan Stanley cut their price objective on UnitedHealth Group from $315.00 to $285.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 17th. Finally, ValuEngine downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, February 27th. One research analyst has rated the stock with a sell rating, two have issued a hold rating, eighteen have given a buy rating and one has issued a strong buy rating to the stock. The company presently has an average rating of “Buy” and a consensus price target of $290.84.
In related news, Director Gail R. Wilensky sold 2,930 shares of the company’s stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $253.39, for a total transaction of $742,432.70. Following the completion of the sale, the director now directly owns 64,726 shares in the company, valued at approximately $16,400,921.14. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Richard T. Burke sold 5,000 shares of the company’s stock in a transaction on Tuesday, March 12th. The stock was sold at an average price of $245.01, for a total value of $1,225,050.00. Following the sale, the director now owns 182,372 shares of the company’s stock, valued at $44,682,963.72. The disclosure for this sale can be found here. Insiders sold a total of 27,930 shares of company stock valued at $6,746,683 over the last quarter. Company insiders own 0.87% of the company’s stock.
COPYRIGHT VIOLATION NOTICE: “Delta Capital Management LLC Sells 6,955 Shares of UnitedHealth Group Inc (UNH)” was first published by Fairfield Current and is the property of of Fairfield Current. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.fairfieldcurrent.com/news/2019/05/24/delta-capital-management-llc-sells-6955-shares-of-unitedhealth-group-inc-unh.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: Trading Ex-Dividend Strategy
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.